RegSmart Life Science AB

Wusson Accelerator AB

Founder of Bioarctic, Lars Lannfelt, is honoured: “I want to create something for the future”

It´s like a scientist’s dream: to be the world’s first with a drug that genuinely affects one of our major diseases. Lars Lannfelt and his company Bioarctic hav...

Nanexa develops depot formulation of the diabetes and obesity drug Saxenda

Uppsala-based company Nanexa has signed an agreement with a German contract research company to start a clinical study with a monthly depot of liraglutide. The ...

Festo liquid dispensing: going fast and slow

Dispensing liquid with Festo equipment developed for automation can really be adapted to your needs

Anna Törner: The clinical trial – Periscope to reality

What happens to the patients in the clinical trial is not very interesting, writes Anna Törner in a column.

Moderna fälls efter 20 000-kronorserbjudande till barn

Moderna kritiseras i Storbritannien för ett felaktigt meddelande där barn erbjöds 1 500 pund, motsvarande över 20 000 kronor, för deltagande i en klinisk studie...

MSD lägger ned två Keytruda-studier

Amerikanska MSD har avbrutit två studier i sen fas där bolagets storsäljande immunterapi Keytruda prövats som behandling mot hud- respektive lungcancer.

Marie Gårdmark: ”Interchangeable biological medicines – soon in a pharmacy near you?”

”Generic competition is an effective way to push down drug prices, but it has not worked equally well for biosimilars. Biosimilars require more time to gain mar...

ZEISS Metrology Expert Tips

New video series provides valuable expert knowledge.

The impact of the recession on the Swedish medtech sector

We need health care regardless of whether the economy is good or bad, but the current recession also affects the Medtech sector.

He will be the new chair of Medicon Valley Alliance

Niels Abel Bonde is the nomination committee’s proposal and the most likely person to take over as the new chairman of the Swedish-Danish life science cluster o...

“A major energy boost for the entire cancer vaccine field”

The development of cancer vaccines has accelerated in recent years. Norwegian Ultimovacs is one of the companies attempting to develop a new type of treatment l...

Ny cellterapi ger hopp om bot för typ 1-diabetes – ”Aldrig lyckats tidigare”

För första gången har en patient med typ 1-diabetes fått en ö-transplantation med genmodifierade insulinproducerande celler, som inte kräver immundämpande läkem...

Nya gripdon från Gimatic stärker OEM Automatics automationslösningar

OEM Automatic har inlett ett strategiskt samarbete med Gimatic, en global ledare inom elektroniska och mekaniska gripdon för industriell automation. Genom detta...

Clinigen Clinical Supplies Management GmbH

Improve your secondary battery manufacturing

SMC provides a large portfolio of products specially designed for secondary battery industry.

Marie Gårdmark: ”The situation is not satisfactory”

”The legislative tool-box is limited, but carrots in the form of longer exclusivity has already proven successful, this has for example increased registration o...

A new special edition and a new event in Copenhagen – This is happening at Life Science Sweden 2024

The new year brings new features for the readers of Life Science Sweden.

A modular system for precise and automated cell dispensing

How the benefits of laboratory automation can be combined with gentle cell handling.

TCO easy comparison of electric and pneumatic solutions

Find the right technology for your application and compare CO₂ emission and TCO The shown results are not based on a sizing calculation, parameters like service...

Möte om framtidens diagnostik igång i Stockholm

Labb och diagnostik står på agendan vid ett möte i Life City på onsdagen i Hagastaden.

She is Sweden´s new Minister of Healthcare

Today, Tuesday, Swedish Prime Minister Ulf Kristersson, who leads the Moderate Party and the centre-right coalition in Sweden, presented the government's new mi...

Sweden and Denmark – this is how they choose their strategies

Scandinavia’s two major powers in pharmaceutical research have developed strategies for growth in life science, and both countries aim to become world leaders.